Johnson & Johnson's number of employees 2004-2023
As of year-end 2023, Johnson & Johnson had around 132 thousand employees. Johnson & Johnson is a pharmaceutical and medical technology company based in New Brunswick, New Jersey. The company's roots can be traced back to 1886, when J&J brought its first line of products on the market - among others, for example, surgical dressings.
Johnson & Johnson global positioning
Johnson & Johnson is among the top pharmaceutical companies globally, in many ways. As of 2022, Johnson & Johnson was among the top three global pharmaceutical companies by prescription sales and research and development spending. When viewed by market capitalization, Johnson & Johnson is currently the second ranked company.
Johnson & Johnson company segments
Within Johnson & Johnson there are many different company segments and product types. One of Johnson & Johnson’s long-time best-selling pharmaceutical products is Remicade. Remicade is a medication used to treat Crohn’s disease and some kinds of arthritis. Among Johnson & Johnson’s medical devices and diagnostic products, their surgery segment generated the most revenue in recent years. In 2023, Johnson & Johnson’s consumer healthcare segment was spun off, establishing a separate company. .
Johnson & Johnson global positioning
Johnson & Johnson is among the top pharmaceutical companies globally, in many ways. As of 2022, Johnson & Johnson was among the top three global pharmaceutical companies by prescription sales and research and development spending. When viewed by market capitalization, Johnson & Johnson is currently the second ranked company.
Johnson & Johnson company segments
Within Johnson & Johnson there are many different company segments and product types. One of Johnson & Johnson’s long-time best-selling pharmaceutical products is Remicade. Remicade is a medication used to treat Crohn’s disease and some kinds of arthritis. Among Johnson & Johnson’s medical devices and diagnostic products, their surgery segment generated the most revenue in recent years. In 2023, Johnson & Johnson’s consumer healthcare segment was spun off, establishing a separate company. .
